Clinical variables evaluated included the presence of coronary artery disease, diabetes, dyslipidemia, heart failure, hypertension, and medications (angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, aspirin, beta-blockers, calcium channel blockers, diuretics, and statins). This evidence concerns the gene ACE and hypertensive disorder.